Beximco Pharmaceuticals Ltd.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:10 |
Report Publication Announcement
Request of Extension to Publish Q1 Results
|
English | 11.2 KB | ||
| 2025-11-04 08:25 |
Regulatory Filings
Change of Name to Beximco Pharmaceuticals PLC.
|
English | 10.8 KB | ||
| 2025-10-27 16:53 |
Report Publication Announcement
Request of Extension to Publish Financial Results
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
United States of America
NRSN
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden
NEWBRY
Sweden
NEWBRY
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden
NNH
Sweden
NNH
Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.
Italy
NWRN
Italy
NWRN
Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.
United States of America
NXGL
United States of America
NXGL
Develops polymer-based drug-device solutions for hemostasis and drug delivery worldwide.
South Korea
389650
South Korea
389650
Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.
Sweden
NXTCL
Sweden
NXTCL
Clinical-stage biopharma developing novel immunomedicines for cancer and other diseases.
United States of America
NXTC
United States of America
NXTC
Develops and commercializes a patented NAD+ precursor for supplements, food, beverage & skincare.
United States of America
NAGE
United States of America
NAGE
Biotech CDMO creating regenerative products with peptide and biomaterial technologies.
South Korea
138610
South Korea
138610